Recent advances in lateral flow devices and point-of-care diagnostics for highly pathogenic avian influenza A viruses
Open Access
- 25 November 2025
- journal article
- review article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 99 (11) , e0148425
Abstract
There has been a resurgence and ongoing outbreak of avian influenza since early 2024. Avian influenza, caused by influenza A viruses, poses significant threats to both avian populations and public health due to its zoonotic potential. Highly pathogenic avian influenza (HPAI) virus, such as the H5N1 and H7 subtypes, has a high mortality rate. Traditional detection methods, i.e., virus isolation and reverse transcription quantitative PCR (qRT-PCR), are reliable for diagnosis but time-consuming and labor-intensive. Rapid and accurate detection of avian influenza A viruses is crucial to prevent widespread outbreaks and minimize economic losses. Field-ready and point-of-care (POC) diagnostics, such as lateral flow assays (LFAs) offer a rapid, early, and large-scale approach for detecting avian influenza A virus infections. Early detection in HPAI management is a key factor in improving treatment effectiveness and reducing the negative impact on animal health. This minireview introduces the principles and techniques of current field-ready and POC diagnostics, emphasizing LFAs for HPAI detection. It also outlines and compares their development, applications, and availability in the market. Notably, advanced techniques such as LFAs-integrated clustered regularly interspaced short palindromic repeats (CRISPR) have expanded HPAI diagnostic capabilities and have also been reviewed. CRISPR-based LFAs use guide RNA to detect viral sequences, activating Cas enzymes that generate a visible signal on test strips, enabling a rapid and sensitive detection method. To our knowledge, this is the first comprehensive review summarizing LFA-based HPAI diagnostics in the context of the 2024 resurgence, offering timely insight into their potential roles in outbreak preparedness and response.Keywords
Funding Information
- U.S. Department of Agriculture (2030-32000-011-00D)
This publication has 96 references indexed in Scilit:
- Veterinary products2025
- Recent developments and future directions in point-of-care next-generation CRISPR-based rapid diagnosisClinical and Experimental Medicine, 2025
- State‐of‐the‐art in food safety: The potential of CRISPR/Cas‐based lateral flow assay technology in the field of food analysisFood Safety and Health, 2024
- CRISPR/Cas-based nucleic acid detection strategies: Trends and challengesHeliyon, 2024
- Emerging trends in nanomaterial design for the development of point-of-care platforms and practical applicationsJournal of Pharmaceutical and Biomedical Analysis, 2023
- An internet of things-based point-of-care device for direct reverse-transcription-loop mediated isothermal amplification to identify SARS-CoV-2Biosensors and Bioelectronics, 2021
- Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID‐19 pandemicJournal of Medical Virology, 2021
- A self-calibrating electrochemical aptasensing platform: Correcting external interference errors for the reliable and stable detection of avian influenza virusesBiosensors and Bioelectronics, 2020
- Avian-to-Human Receptor-Binding Adaptation of Avian H7N9 Influenza Virus HemagglutininCell Reports, 2019
- Genetic Characterization of the Pathogenic Influenza A/Goose/Guangdong/1/96 (H5N1) Virus: Similarity of Its Hemagglutinin Gene to Those of H5N1 Viruses from the 1997 Outbreaks in Hong KongVirology, 1999